Submission Details
| 510(k) Number | K050665 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 15, 2005 |
| Decision Date | May 02, 2005 |
| Days to Decision | 48 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
K050665 is an FDA 510(k) clearance for the N ANTISERA TO HUMAN COMPLEMENT FACTORS (C3C, C4), a Complement C3, Antigen, Antiserum, Control (Class II — Special Controls, product code CZW), submitted by Dade Behring, Inc. (Newark, US). The FDA issued a Cleared decision on May 2, 2005, 48 days after receiving the submission on March 15, 2005. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5240.
| 510(k) Number | K050665 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 15, 2005 |
| Decision Date | May 02, 2005 |
| Days to Decision | 48 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
| Product Code | CZW — Complement C3, Antigen, Antiserum, Control |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5240 |